Tengjun Biotechnology Corp.: auditor change — Tengjun Biotechnology restates FY2022 financials, appoints new CEO/CFO after prior officer's death

Tengjun Biotechnology Corp.

Board determined FY2022 financial statements unreliable due to accounting errors; restatement via amended 10-K planned.
Previous Director, CEO, and CFO Xianchang Ma passed away on August 3, 2023.
Ms. Caihong Qu appointed as Director, interim CEO, and CFO effective August 10, 2023.
Ms. Qu (age 48) is the late wife of Mr. Ma and legal rep of Jinxiang County Kanglong Water Purification Equipment Co., Ltd.

item 4.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Caihong Qu

Interim Chief Executive Officer and Chief Financial Officer

Tengjun Biotechnology Corp.

Effective: 2023-08-10
Filed: August 14, 2023, 7:59 PM ET

On August 10, 2023, the Board resolved to appoint Ms. Caihong Qu as a member of the Board and the interim Chief Executive Officer and Chief Financial Officer of the Company, until the next annual meeting of the Corporation’s shareholders, and until her successor is elected and qualified or until her prior disqualification.

Departed

Xianchang Ma

Director, Chief Executive Officer and Chief Financial Officer

Tengjun Biotechnology Corp.

Effective: 2023-08-03
Successor: Caihong Qu
Filed: August 14, 2023, 7:59 PM ET

Ms. Qu is the late wife of Mr. Xianchang Ma, our previous Director, CEO and CFO, who passed away on August 3, 2023.

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Tengjun Biotechnology Corp. reported that prior financial statements should not be relied upon.

Action: non reliance

Exact text from the filing

the Company’s Board of Directors (the “Board”) concluded that the Company’s previously issued financial statements, contained within its Annual Report on Form 10-K for the fiscal year ended December 31, 2022, should no longer be relied upon due to accounting methodology errors in such financial statements

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Caihong Qu was appointed as Interim Chief Executive Officer and Chief Financial Officer at Tengjun Biotechnology Corp..

Action: appointed
Role: Interim Chief Executive Officer and Chief Financial Officer

Exact text from the filing

On August 10, 2023, the Board resolved to appoint Ms. Caihong Qu as a member of the Board and the interim Chief Executive Officer and Chief Financial Officer of the Company, until the next annual meeting of the Corporation’s shareholders, and until her successor is elected and qualified or until her prior disqualification.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Xianchang Ma departed as Director, Chief Executive Officer and Chief Financial Officer at Tengjun Biotechnology Corp..

Action: passed away
Role: Director, Chief Executive Officer and Chief Financial Officer

Exact text from the filing

Ms. Qu is the late wife of Mr. Xianchang Ma, our previous Director, CEO and CFO, who passed away on August 3, 2023.

View on SEC.gov

6 auditor changes filed in the last 30 days. Browse all auditor changes →

Source: SEC EDGAR

accession 0001213900-23-067084

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.